Do Etomidate and Propofol Increase Mortality in the Critically Ill?

Update: 2023-06-15

Description

Both etomidate and propofol are commonly used sedative agents in critically ill patients. Recent literature has suggested that these agents may result in increased harm and mortality. In this podcast, we discuss the most recent two systematic reviews and meta-analyses that evaluated etomidate and propofol in critically ill patients. Do we need to change our practice?

Comments

In Channel

Critical Issues in ED Intubation

2025-10-1534:24

Dexmedetomidine or Propofol for Sedation in the Critically Ill?

2025-07-0721:54

Palliative Care in the ED

2025-05-1726:02

When Should We Start Vasopressin in Septic Shock?

2025-04-1525:31

Is HFNC noninferior to NIV for Acute Respiratory Failure?

2025-01-2431:44

High-Intensity NIPPV for Acute COPD Exacerbations?

2024-12-0525:46

Naloxone for OHCA?

2024-11-0122:22

Continuous or Intermittent B-Lactam Infusions for Sepsis?

2024-09-2429:51

What Oxygenation Strategy Should We Use for COVID-19 Patients?

2024-07-2720:23

Should We Use NIPPV for Preoxygenation for All Intubations?

2024-07-0926:28

Cefepime vs. Piperacillin-Tazobactam for Infection? The ACORN Trial

2024-06-0722:24

Are We Ventilating our OHCA Patients?

2024-04-2418:44

Steroids in Sepsis, ARDS, and CAP - A Focused Clinical Update

2024-03-1722:04

Should We Intubate For GCS < 8?

2023-12-2924:55

Should We Be Placing REBOA?

2023-11-2324:31

SCCM Guidelines for RSI in the Critically Ill

2023-10-2433:10

Post-Arrest Care Updates - Are Mild Hypercapnia and a Pan-CT Protocol Useful?

2023-09-0834:29